Amphastar Pharmaceuticals Inc (AMPH)
46.72
+0.40
(+0.86%)
USD |
NASDAQ |
Oct 04, 16:00
46.72
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Shareholders Equity (Annual): 639.42M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 639.42M |
| December 31, 2022 | 528.66M |
| December 31, 2021 | 445.52M |
| December 31, 2020 | 402.31M |
| December 31, 2019 | 381.37M |
| December 31, 2018 | 332.44M |
| Date | Value |
|---|---|
| December 31, 2017 | 333.74M |
| December 31, 2016 | 329.26M |
| December 31, 2015 | 295.51M |
| December 31, 2014 | 281.86M |
| December 31, 2013 | 251.54M |
| December 31, 2012 | 233.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
381.37M
Minimum
2019
639.42M
Maximum
2023
479.45M
Average
445.52M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Omeros Corp | -24.98M |
| Harrow Inc | 70.77M |
| PetIQ Inc | 221.21M |
| Amneal Pharmaceuticals Inc | 19.78M |
| Alector Inc | 134.16M |